IA
CSTL icon

IFP Advisors’s Castle Biosciences CSTL Stock Holding History

IFP Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Hold
52
– – ﹤0.01% 4121
2025
Q4 		$2.02K Hold
52
– – ﹤0.01% 3832
2025
Q3 		$1.18K Buy
52
+16
+44% +$325 ﹤0.01% 3890
2025
Q2 		$1.27K Buy
+36
New +$666 ﹤0.01% 4122
2025
Q1 		– Sell
-161
Closed -$4.29K – 4386
2024
Q4 		$4.29K Buy
+161
New +$4.9K ﹤0.01% 2845
2023
Q3 		– Sell
-11
Closed -$151 – 3351
2023
Q2 		$151 Hold
11
– – ﹤0.01% 3332
2023
Q1 		$235 Hold
11
– – ﹤0.01% 3261
2022
Q4 		$1K Buy
+11
New +$255 ﹤0.01% 4308

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's CSTL Position: Q1 2026 in Review

IFP Advisors held its Castle Biosciences (CSTL) position steady in Q1 2026 at 52 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #4121.

IFP Advisors first reported a position in CSTL in Q4 2022 and has held it in 8 quarters since. The position peaked at $4.29K in Q4 2024. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • IFP Advisors held 52 shares of Castle Biosciences worth $1.28K as of Q1 2026.
  • IFP Advisors left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4121 holding.
  • IFP Advisors first reported a position in Castle Biosciences in Q4 2022 and has held it in 8 quarters since.
  • IFP Advisors's Castle Biosciences position peaked at $4.29K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.